Genmab — Januar 2022
-
Fy for den lede. Hvad gør man på en dag som idag udover at kigge væk
-
Afsnit 99 af Investeringspodcasten - Omikron og 'Tip en 20 https://www.proinvestor.com/index.php?p=debat_1&postid=99916
-
Barclays analyst Emily Field reiterated an Overweight rating and DKK3,100.00 price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB). https://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Overweight+Rating+on+Genmab+AS+(GEN%3ADC)+(GMAB)/19421625.html?classic=1
-
Klarussen. Virker da fint her?
-
Som I nok har opdaget, så falder aktierne i dag. Men hvorfor? Og hvorfor så kraftigt?
Her får I lige en lille video, hvor Hans-Henrik Nielsen kigger på inflation, renter osv. https://www.proinvestor.com/boards/99919/Hvorfor-falder-aktierne?-
-
Jeg forstår godt, at folk går i panik, hvis de handler med lånte penge - ellers forstår jeg intet af det her. Det er total overreaktion. Men godt man er langsigtet og kan købe billigt op. Nu får US igen nogle billige danske aktier. Og jeg tror på, at alt stiger igen i eftermiddag eller i morgen.
-
RBC research from November21, mentions Genmab in the Best Ideas for the Long Term. p 4 & 30. https://ca.rbcwealthmanagement.com/documents/622058/622074/2021-11-18+RBC+Imagine+8482+Best+Ideas+for+the+Long+Term.pdf/343fac2a-3f61-466f-a9fa-1293988c1312
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind